Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder
- 27 August 2008
- journal article
- research article
- Published by Elsevier in Psychiatry Research
- Vol. 161 (1) , 116-120
- https://doi.org/10.1016/j.psychres.2008.02.011
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Efficacy of Bupropion and the Selective Serotonin Reuptake Inhibitors in the Treatment of Major Depressive Disorder With High Levels of Anxiety (Anxious Depression)The Journal of Clinical Psychiatry, 2008
- Difference in Treatment Outcome in Outpatients With Anxious Versus Nonanxious Depression: A STAR*D ReportAmerican Journal of Psychiatry, 2008
- Efficacy of Duloxetine and Selective Serotonin Reuptake InhibitorsJournal of Clinical Psychopharmacology, 2007
- Resolution of Sleepiness and Fatigue in Major Depressive Disorder: A Comparison of Bupropion and the Selective Serotonin Reuptake InhibitorsBiological Psychiatry, 2006
- Somatic Symptoms in Outpatients With Major Depressive Disorder Treated With FluoxetinePsychosomatics, 2006
- Major depressive subtypes and treatment responseBiological Psychiatry, 1997
- Residual symptoms after partial remission: an important outcome in depressionPsychological Medicine, 1995
- Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter studyJournal of Affective Disorders, 1990
- A Structured Interview Guide for the Hamilton Depression Rating ScaleArchives of General Psychiatry, 1988
- Antidepressant Specificity in Atypical DepressionArchives of General Psychiatry, 1988